Nanxin Zheng
Overview
Explore the profile of Nanxin Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang C, Chen J, Zheng N, Zheng K, Zhou L, Zhang Q, et al.
Front Oncol
. 2023 Sep;
13:1109588.
PMID: 37746305
Objective: To assess the prognostic value of a model based on pre-treatment T2WI-based radiomic features and postoperative pathological staging in patients with locally advanced rectal cancer who have undergone neoadjuvant...
2.
Zheng N, Wang H, Yu Q, Wang C, Bai C, Pan A, et al.
Int J Surg
. 2023 Mar;
109(4):772-784.
PMID: 36999800
Background: With the elimination of schistosomiasis in China, its role in the pathogenesis of colorectal cancer (CRC) has decreased. However, the trends, clinicopathological features, surgical treatment patterns, and prognosis of...
3.
Zheng N, Wen R, Zhou L, Meng Q, Zheng K, Li Z, et al.
Transl Oncol
. 2022 Nov;
27:101570.
PMID: 36371957
Background: The tumor microenvironment (TME) plays a critical role in shaping tumor progression and determining the outcome of the therapeutic response. In this study, we aimed to generate a comprehensive...
4.
Liu Z, Zheng N, Li J, Li C, Zheng D, Jiang X, et al.
Drug Resist Updat
. 2022 Nov;
65:100886.
PMID: 36370665
Background: Colorectal cancer (CRC) is the 3rd most common cancer worldwide. CircRNAs are promising novel biomarkers for CRC. T regulatory (Treg) cells express the immune checkpoint receptor of cytotoxic T-lymphocyte-associated...
5.
Chong X, Chen J, Zheng N, Zhou Z, Hai Y, Chen S, et al.
Mol Cancer
. 2022 May;
21(1):118.
PMID: 35619132
Background: PIK3CA mutation and PTEN suppression lead to tumorigenesis and drug resistance in colorectal cancer (CRC). There is no research on the role of circular RNAs (circRNAs) in regulating PIK3CA...
6.
Sui M, Zheng N, Xu D, Li Y, Li Y, Pu S, et al.
Transpl Infect Dis
. 2022 Mar;
24(3):e13820.
PMID: 35279926
Background: Preservation fluid (PF) contamination, especially by multidrug-resistant (MDR) Gram-negative bacteria (GNB), poses a high risk of donor-derived infection (DDI) and severe clinical outcomes. We sought to determine whether the...
7.
Meng Q, Zheng N, Wen R, Sui J, Zhang W
J Gastrointest Oncol
. 2021 May;
12(2):556-567.
PMID: 34012649
Background: Simultaneous resection for patients with synchronous colorectal cancer liver metastases (CRLM) remains an optimal option for the sake of curability. However, few studies so far focus on outcome of...
8.
Zheng K, Zheng N, Xin C, Zhou L, Sun G, Wen R, et al.
Gastroenterol Res Pract
. 2020 Oct;
2020:1848252.
PMID: 33014036
[This corrects the article DOI: 10.1155/2020/2052561.].
9.
Zheng K, Zheng N, Xin C, Zhou L, Sun G, Wen R, et al.
Gastroenterol Res Pract
. 2020 Apr;
2020:2052561.
PMID: 32256564
Background: The prognostic value of tumor deposit (TD) count in colorectal cancer (CRC) patients has been rarely evaluated. This study is aimed at exploring the prognostic value of TD count...
10.
Wang J, Lu H, Wang W, Zheng N, Wang Y, Hu Z, et al.
Front Oncol
. 2019 Nov;
9:1096.
PMID: 31696055
Hepatocyte nuclear factor 3β (HNF3β) is a key transcription factor in the development of the gastrointestinal tract. However, only few studies have examined its' expression, function and potential clinical significance...